Patents by Inventor Eric Rimm

Eric Rimm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR ASSESSING CARDIOVASCULAR DISEASE
    Publication number: 20150168428
    Abstract: Some aspects of this disclosure relate to the characterization of lipoproteins (e.g., vLDL, LDL, and/or HDL) based on their content of lipoprotein-associated proteins (e.g., apolipoproteins) for the determination of cardiovascular disease risk. Some aspects of this disclosure relate to methods for the diagnosis, early detection, risk estimation and monitoring of the course of diseases, in which one or more lipoprotein-associated protein is detected in a lipoprotein. The characterization of the levels of lipoproteins with different lipoprotein-associated protein content provide an index for assessing the risk of a disease, for example, a cardiovascular disease.
    Type: Application
    Filed: May 9, 2013
    Publication date: June 18, 2015
    Inventors: Frank M. Sacks, Eric Rimm, Majken Jensen, Jeremy D. Furtado
  • Association of levels of HDL-cholesterol apolipoprotein CIII with the risk of coronary heart disease and cardiovascular events
    Patent number: 8846321
    Abstract: Presented herein are methods of diagnosing, assessing, and treating an individual at increased risk if developing coronary heart disease or cardiovascular event, based on the individual's level of high density lipoprotein cholesterol apoCIII (HDL-C apoCIII).
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: September 30, 2014
    Assignee: President and Fellows of Harvard College
    Inventors: Frank M. Sacks, Jeremy D. Furtado, Eric Rimm, Majken Jensen
  • ASSOCIATION OF LEVELS OF HDL-CHOLESTEROL APOLIPOPROTEIN CIII WITH THE RISK OF CORONARY HEART DISEASE AND CARDIOVASCULAR EVENTS
    Publication number: 20110223158
    Abstract: Presented herein are methods of diagnosing, assessing, and treating an individual at increased risk if developing coronary heart disease or cardiovascular event, based on the individual's level of high density lipoprotein cholesterol apoCIII (HDL-C apoCIII).
    Type: Application
    Filed: March 11, 2011
    Publication date: September 15, 2011
    Applicant: President and Fellows of Harvard College
    Inventors: Frank M. Sacks, Jeremy D. Furtado, Eric Rimm, Majken Jensen